Cargando…
The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study
INTRODUCTION: Symptomatic uncomplicated diverticular disease of the colon (SUDD) is one of the most common diseases with which patients present to a gastroenterologist. Mild forms of diverticulitis can also be treated using rifaximin. Although numerous randomised controlled trials have already demon...
Autores principales: | Moniuszko, Andrzej, Rydzewska, Grażyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497137/ https://www.ncbi.nlm.nih.gov/pubmed/28702105 http://dx.doi.org/10.5114/pg.2017.68167 |
Ejemplares similares
-
Cyclic rifaximin therapy effectively prevents the recurrence of symptoms after exacerbation of symptomatic uncomplicated diverticular disease: a retrospective study
por: Pietrzak, Anna M., et al.
Publicado: (2019) -
Diverticular Disease and Rifaximin: An Evidence-Based Review
por: Piccin, Anna, et al.
Publicado: (2023) -
Diagnosis of symptomatic uncomplicated diverticular disease and the role of Rifaximin in management
por: Maconi, Giovanni
Publicado: (2017) -
DIVERTICULAR DISEASES (CLINICS IN GASTROENTEROLOGY Vol. 4, No. 1)
Publicado: (1975) -
The efficacy and safety of the biosimilar product (Inflectra(®)) compared to the reference drug (Remicade(®)) in rescue therapy in adult patients with ulcerative colitis
por: Kaniewska, Magdalena, et al.
Publicado: (2017)